Akari Therapeutics (AKTX) Insider Trading & Ownership $0.93 -0.09 (-8.82%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$0.92 -0.01 (-0.54%) As of 10/10/2025 07:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Akari Therapeutics (NASDAQ:AKTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage38.10%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$38.66KNumber OfInsiders Selling(Last 12 Months)0 Get AKTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Akari Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AKTX Insider Buying and Selling by Quarter Akari Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/25/2025Abizer GaslightwalaCEOBuy3,000$0.90$2,700.00 8/22/2025Abizer GaslightwalaCEOBuy8,000$0.93$7,440.00 8/21/2025Abizer GaslightwalaCEOBuy10,000$0.94$9,400.00 6/24/2025Abizer GaslightwalaCEOBuy5,203$1.16$6,035.48 6/23/2025Abizer GaslightwalaCEOBuy943$1.15$1,084.45 6/20/2025Abizer GaslightwalaCEOBuy10,000$1.20$12,000.00 (Data available from 1/1/2013 forward) AKTX Insider Trading Activity - Frequently Asked Questions Who is on Akari Therapeutics' Insider Roster? The list of insiders at Akari Therapeutics includes Abizer Gaslightwala. Learn more on insiders at AKTX. What percentage of Akari Therapeutics stock is owned by insiders? 38.10% of Akari Therapeutics stock is owned by insiders. Learn more on AKTX's insider holdings. Which Akari Therapeutics insiders have been buying company stock? The following insider purchased AKTX shares in the last 24 months: Abizer Gaslightwala ($38,659.93). How much insider buying is happening at Akari Therapeutics? Insiders have purchased a total of 37,146 AKTX shares in the last 24 months for a total of $38,659.93 bought. Akari Therapeutics Key ExecutivesMs. Rachelle Suzanne Jacques (Age 53)President, CEO & Director Compensation: $632.25kMs. Wendy F. DiCicco CPA (Age 57)Interim Chief Financial Officer Compensation: $540.34kMs. Melissa Bradford-Klug (Age 54)Chief Operating Officer Dr. Miles Nunn (Age 55)Chief Scientific Officer Dr. John F. Neylan III (Age 71)M.D., Executive VP & Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies Biomea Fusion Insider Buying TuHURA Biosciences Insider Buying Ovid Therapeutics Insider Buying Fate Therapeutics Insider Buying Alpha Cognition Insider Buying Instil Bio Insider Buying Anixa Biosciences Insider Buying Zentalis Pharmaceuticals Insider Buying Atossa Genetics Insider Buying MacroGenics Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Marvell Insiders Buy Shares—Should Investors Follow Suit?This Insider Just Made a Massive Bet on Transocean's ComebackInsider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t WorryTop Insider Buys and Sells From September: Buy, Sell, or Hold? This page (NASDAQ:AKTX) was last updated on 10/12/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored7 market signals flashing red right nowRight now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all...American Alternative | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredGOLD ALERTGold has shattered records, soaring past $3,800 an ounce... But Stansberry Senior Partner Dr. David "Doc" E...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akari Therapeutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Akari Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
